NeuroBo Pharma (NRBO) Bozor qiymatining balans qiymatiga nisbati
NeuroBo Pharmaceuticals dori vositalarini ishlab chiqishda butunlay tashqi pudratchilarga (CRO va CMO) tayanadi. GURU.Markets platformasidagi kitob qiymatiga nisbatan narx tendentsiyasi ushbu ko'rsatkich 1.60 ga teng ekanligini ko'rsatmoqda. NRBO muvaffaqiyati FDA tasdig'i va yangi investitsiyalarga bog'liq. Kompaniya hozirda keyinchalik global bozorga chiqarish uchun semizlikka qarshi dori vositalari portfelini kengaytirishni jadallashtirmoqda.
NeuroBo Pharmaceuticals Inc (NRBO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati NeuroBo Pharmaceuticals|NRBO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati NeuroBo|NRBO - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati NeuroBo|NRBO - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzlari NeuroBo Pharmaceuticals
Kompaniyaning har tomonlama tahlili:NeuroBo Pharmaceuticals
Ushbu ko'rsatkich inflyatsiyaviy bosim sharoitida kompaniyaning bozor qiymatining uning sof aktivlaridan yuqori ekanligini aks ettiradi. Hisob-kitoblar bozor kapitalizatsiyasini balans qiymatiga bo'lishga asoslangan bo'lib, resurslar kapitalizatsiyasining samaradorligini o'lchaydi. Bozor qiymatining balans qiymatiga nisbatini tahlil qilish biznesni qayta baholash tendentsiyalarini aniqlash imkonini beradi. NeuroBo Pharmaceuticals (NRBO) uchun ushbu metrikaning o'sishi metabolik kasalliklar sohasidagi yuqori daromadli ishlanmalarga e'tiborning ko'chishi bilan bog'liq. Bunday strategik portfel diversifikatsiyasi aktivlarning investitsiya jozibadorligini bevosita oshiradi.
Muhim raqobatchilar
Biogen Inc. (BIIB) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurocrine.com (NBIX)|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals|Kapitallashuvning balans qiymatiga nisbati TRVI (trevitherapeutics.com)|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|AVXL - Bozor qiymatining balans qiymatiga koeffitsiyenti|CeriBell Corp - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Prothena PRTA|ALEC - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ANNX (annexonbio.com)|omeros.com (OMER) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Neurogene Inc (NGNE)|ACIU (AC Immune Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati VYGR|Bozor qiymatining balans qiymatiga nisbati Neumora Therapeutics (NMRA)|SCLX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Tevogen Bio - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ACOG|CGTX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi IKT|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|Assertio - Balans qiymatiga nisbatan bozor qiymati|COYA (Coya Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VistaGen Therapeutics Inc|Bozor qiymatining balans qiymatiga nisbati Ovid Therapeutics Inc. (OVID)|ABOS (Acumen Pharmaceuticals, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati CervoMed Inc. CRVO|ATHE - Kapitallashuvning sof aktivlarga nisbati|Clene Nanomedicine - Bozor kapitallashuvining balans qiymatiga nisbati|PEPG - Bozor kapitallashuvining balans qiymatiga nisbati|JUNS: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Relmada Corp|ANVS (Annovis Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Grace Tx GRCE|Kapitallashuvning sof aktivlarga nisbati AIFF (Firefly Neuroscience)|Bozor kapitallashuvining balans qiymatiga nisbati anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori RVPH (Reviva Pharmaceuticals, Inc.)|MetaVia, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi neuraxis.com NRXS|HSDT: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Passage Bio|NEUP (Neuphoria Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Minerva|Bozor qiymatining balans qiymatiga nisbati Athira Pharma, Inc. (ATHA)|Bozor qiymatining balans qiymatiga nisbati ADXN (addextherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati Alzamend Neuro ALZN|Balans qiymatiga nisbatan bozor kapitallashuvi Cyclerion Therapeutics Inc. (CYCN)|PTIX - Bozor qiymatining balans qiymatiga nisbati|KTTA (Pasithea Therapeutics) - Kapitallashuvning balans qiymatiga nisbati|cortigent.com (CRGT) - Bozor qiymatining balans qiymatiga nisbati|avenuetx.com - Balans qiymatiga nisbatan bozor qiymati|BCLI (BrainStorm Cell Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati CARA|Bozor qiymatining balans qiymatiga nisbati Chromocell Therapeutics Corporation (CHRO)|ELYM - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Intra-Cellular Therapies, Inc. ITCI|LBPH: Kapitallashuvning balans qiymatiga nisbati|Marinus Pharmaceuticals, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti NKGen Biotech Inc|SAGE (Sage Therapeutics, Inc) - Kapitallashuvning sof aktivlarga nisbati|Synaptogenix, Inc (SNPX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc.|VIGL: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. (WENA)|CERE - Bozor qiymatining balans qiymatiga koeffitsiyenti